Treatment of toxic epidermal necrolysis syndrome with "disease- modifying" drugs: The controversy goes on

Clinics in Dermatology

Volumn 22, Issue 3, 2004, Pages 267-269

  Wolf, Ronni ^a   Ruocco, Vincenzo ^b   Jablonska, Stefania ^c  

^a KAPLAN MEDICAL CENTER   (Israel)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DERMATOLOGICAL AGENT; IMMUNOMODULATING AGENT;

BURN; CLINICAL TRIAL; DERMATOLOGY; DIGESTIVE SYSTEM ULCER; HUMAN; IATROGENIC DISEASE; LEUKOPENIA; NOTE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; STEVENS JOHNSON SYNDROME; THROMBOEMBOLISM; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

EID: 3242687945     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.03.016     Document Type: Article

References (33)

1. Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol. 100:1979;69-86
2. Revuz J., Roujeau J., Guillaume J. Treatment of toxic epidermal necrolysis: Creteil's experience. Arch Dermatol. 123:1987;1156-1158
3. Roujeau J., Stern R. Severe adverse cutaneous reactions to drugs. N Engl J Med. 331:1994;1272-1285
4. Murphy J., Purdue G., Hunt J. Toxic epidermal necrolysis. J Burn Care Rehabil. 18:1997;417-420
5. Avakian R., Fowlers F., Araujo O., et al. Toxic epidermal necrolysis: a review. J Am Acad Dermatol. 25:1991;69-70
6. Revuz J., Penso D., Roujeau J., et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol. 123:1987;1160-1165
7. Westly E., Wechsler H. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch Dermatol. 120:1984;721-726
8. Rasmussen J. Erythema multiforme in children. Response to treatment with systemic corticosteroids. Br J Dermatol. 95:1976;181-186
9. Anhalt G., Snelling C. Toxic epidermal necrolysis. Plast Reconstr Surg. 61:1978;905-910
10. Bjornberg A. Fifteen cases of toxic epidermal necrolysis. Acta Dermatol Venereol. 15:1973;149-152
11. Ohlenschlaeger K. Toxic epidermal necrolysis and the Stevens-Johnson syndrome. Acta Dermatol Venereol. 46:1966;205-206
12. Sherertz E., Jegasothy B., Lazarus G. Phenytoid hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy." J Am Acad Dermatol. 12:1985;178-181
13. Patterson R., Grammer L., Greenberger P., et al. Stevens-Johnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS. Allergy Proc. 13:1992;89-95
14. Patterson R., Miller M., Kaplan M., et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy. 73:1994;27-34
15. Cheriyan S., Patterson R., Greenberger P., et al. The outcome of Stevens-Johnson syndrome treated with corticosteroids. Allergy Proc. 16:1995;151-155
16. Prendiville J., Hebert A., Greenwald M., et al. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr. 115:1989;881-887
17. Tegelberg-Stassen M., Van Vloten W., Baart de la Faille H. Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories. Dermatologica. 181:1990;237-238
18. Rasmussen J. Toxic epidermal necrolysis. A review of 75 cases in children. Arch Dermatol. 111:1975;1135-1139
19. Halebian P., Corder V., Herndon D., et al. A burn center experience with toxic epidermal necrolysis. J Burn Care Rehabil. 4:1983;176-183
20. Halebian P., Corder V., Madden M., et al. Improved burn center survival of patients with toxic epidermal necrolysis. Ann Surg. 204:1986;503-512
21. Halebian P., Shires G. Burn unit treatment of acute, severe exfoliating disorders. Annu Rev Med. 40:1989;137-147
22. Jones W., Halebian P., Madden M., et al. Drug-induced toxic epidermal necrolysis in children. J Pediatr Surg. 24:1989;167-170
23. Klemen I.J., Cioffi W., McManus W., et al. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg. 180:1995;273-278
24. Sheridan L., Weber J., Schulz J., et al. Management of severe toxic epidermal necrolysis in children. J Burn Care Rehabil. 20:1999;497-500
25. Correia O., Delgado L., Leal Barbosa I., et al. Increased interleukin 10, tumor necrosis factor α, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis. J Am Acad Dermatol. 47:2002;58-62
26. Viard L., Wehrli P., Bullani R., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282:1998;490-493
27. Stella M., Cassano P., Bollero D., et al. Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience. Dermatology. 203:2001;45-49
28. Paquet P., Jacob E., Damas P., et al. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns. 27:2001;652-655
29. Arevalo J., Lorente J., Gonzalez-Herrada C., et al. Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma. 48:2000;473-478
30. Jarrett P., Rademaker M., Havill J., et al. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony-stimulating factor. Clin Exp Dermatol. 22:1997;146-147
31. Stables G., Lever R. Toxic epidermal necrolysis and systemic corticosteroids. Br J Dermatol. 128:1993;357-360
32. Pasricha J., Khaitan B., Shantharaman R., et al. Toxic epidermal necrolysis. Int J Dermatol. 35:1996;523-527
33. Criton S., Devi K., Sridevi P., et al. Toxic epidermal necrolysis - a retrospective study. Int J Dermatol. 36:1997;923-925